Skip to main content
. 2019 Oct 22;10(5):e02059-19. doi: 10.1128/mBio.02059-19

TABLEĀ 2.

Mutations occurring in animal POST1 under oseltamivir treatmenta

Tissue Analysis % of sequence showing mutations (no. of plaques showing mutations/total no. of plaques analyzed)
NA
His275Tyr
HA
Asp187Val
HA
Asp187Asn
HA
Asp222Asn
HA
Asp222Gly
Nasal mucosa Plaque 100 (20/20) 0 (0/20) NT NT NT
Trachea PCR 100 (5/5) 0 (wt) 0 (wt) 75 (3/4) 25 (1/4)
Right bronchus PCR 100 (2/2) 75 (3/4) 0 (wt) 25 (1/4) 0 (wt)
Left bronchus PCR 100 (3/3) 75 (wt) (3/4) 25 (1/4) 25 (1/4) 75 (wt) (3/4)
Right lung upper PCR 0 (wt) 0 (wt) 0 (wt) 0 (wt) 0 (wt)
Right lung middle PCR 0 (wt) 0 (wt) 0 (wt) 0 (wt) 0 (wt)
Right lung caudal Plaque 100 (20/20) 85 (17/20) 15 (3/20) 0 (wt) 0 (wt)
Left lung upper PCR 0 (wt) 0 (wt) 0 (wt) 0 (wt) 0 (wt)
Left lung middle PCR 0 (wt) 0 (wt) 0 (wt) 0 (wt) 0 (wt)
Left lung caudal PCR 0 (wt) 0 (wt) 0 (wt) 0 (wt) 0 (wt)
a

Plaque, virus isolation by plaque assay and subsequent direct sequence determination; PCR, RT-PCR of total RNA isolated from the specimen followed by molecular cloning and sequence determination (2 to 6 individual clones each); NT, not tested; wt, wild-type sequence.